The use of water-soluble synthetic peptide combinatorial libraries permits the systematic examination of tens to hundreds of millions of peptides in existing microdilution assays. In the present study, we prepared and determined the antistaphylococcal activities of two new synthetic peptide combinatorial libraries (one N-acetylated, the other not) composed of tetrapeptides having one position defined and the remaining three positions made up of mixtures of L-, D-, and unnatural amino acids (a total of 58 different amino acids). These libraries, when used in conjunction with an iterative selection process, allowed for the development of a series of individually defined tetrapeptides with high levels of activity against Staphylococcus aureus. The activities of the final individual peptides against two additional strains of gram-positive bacteria (methicillin-resistant S. aureus and Streptococcus sanguis), a gram-negative bacterium (Escherichia coli), as well as the yeast Candida albicans were also determined. Cell viability assays showed that the identified peptides are bacteriostatic against both S. aureus and E. coli.
Staphylococcus aureus continues to be a problematic pathogen because of the increasing occurrence of strains which are resistant to commonly used antibiotics. Such resistant strains lead to a constant need for new antistaphylococcal agents. In recent years, peptides, either isolated from natural sources or synthetically designed, have emerged as potent antimicrobial agents (for a review, see reference 2). However, the process involved in the development of such new antimicrobial peptides, i.e., their isolation and characterization and the synthesis of large numbers of peptide analogs required for activity optimization, is time-consuming and limited by the large number of individual peptides which can be generated and screened. Highly active antimicrobial peptides have recently been identified through the use of soluble (i.e., non-supportbound), synthetic peptide combinatorial libraries (SPCLs [11, 12, 14, 15] ) made up of L-amino acids. This approach permits the systematic screening of hundreds of millions to billions of peptides for the identification of optimal, biologically active peptides (1, 7, 8, 11, 15, 18) . Since these newly developed antimicrobial peptides are composed entirely of L-amino acids and are therefore susceptible to proteolytic breakdown and rarely have activity when administered orally, their therapeutic applicability is limited to topical or intravenous use. Antimicrobial peptides with D-and/or unnatural amino acids in their sequences would be expected to enhance the stabilities of these peptides toward proteolysis and, in turn, increase their duration of activity and applicability. In the present study, we extended our search for new antimicrobial agents by determining the activities of two new SPCLs made up of L-, D-and unnatural amino acids against S. aureus. The spectra of activity of the final individual peptides, as well as their toxicities, are described.
MATERIALS AND METHODS
Synthesis of SPCLs and individual peptides. The peptide mixtures making up each of the two SPCLs, as well as those used in the iterative process, were prepared by the process of divide, couple, and recombine (9, 15, 17) in conjunction with simultaneous multiple-peptide synthesis (10) . All individual peptides were prepared by simultaneous multiple-peptide synthesis. Peptide mixtures and individual peptides were cleaved from the resulting resins by using low to high concentrations of hydrogen fluoride (13, 20) . Twenty-four peptides were individually cleaved simultaneously with HF by using a multiple-vessel cleavage apparatus (Chiron Mimotopes Peptide Systems, San Diego, Calif.) (13) . Peptides were exhaustively extracted with Table 1 . Each individual bar is segregated by the first amino acid in the peptide mixtures (U) and represents the percent inhibition of S. aureus growth at a peptide mixture concentration of 2.5 mg/ml. water and lyophilized. The identities of the individual peptides were determined by laser desorption time-of-flight mass spectroscopy (MALDI-TOF mass spectrometer; Kratos Analytical, Ramsey, N.J. Louis, Mo.) to each well and serially diluting the peptides in the serum or albumin solution. The assays were then carried out as described above. Hemolytic assays. The peptides' hemolytic activities were determined by using human erythrocytes (RBCs). The assays were carried out in 96-well flat-bottom plates against a 0.25% RBC suspension as described elsewhere (3). In brief, peptide mixtures were added to the RBC solution at concentrations that varied from 500 to 4 ,ug/ml in serial twofold dilutions. Following a 1-h incubation at 37°C, the plates were centrifuged at 2,800 rpm for 5 min. The supernatant was separated from the pellet, and its optical density at 414 nm was measured. The hemolytic dose to lyse 50% of RBCs (HD50) was calculated by using the sigmoidal curve-fitting software Graphpad.
RESULTS
Preparation of the two SPCLs. The two SPCLs used in the present study, one N-acetylated, the other not, were composed of tetrapeptides in which the first position was defined (U) and three positions (Z) were an equimolar mixture of 56 different L-, D-, and unnatural amino acids (19 L-, 18 D-, and 19 unnatural amino acids; L-and D-cysteine were omitted from the mixture positions but were included in the defined positions). The two SPCLs can be represented by the general formula Ac-UZZZ-NH2 and UZZZ-NH2. The 19 unnatural amino acids used in the study are listed in Table 1 . These were chosen according to their diversities and commercial availabilities. Each tetrapep- The percent inhibition at a concentration of 2.5 mg of each peptide mixture per ml is shown in Fig. 1 . The IC50s were then determined for those peptide mixtures which exhibited more than 50% inhibition at 2.5 mg/ml. Overall, the non-N-acetylated peptide mixtures were found to be more active than the corresponding N-acetylated ones. The peptide mixture (Table 2) and MICs ranging from 3 to 16 ,ug/ml (Table 3) . It is noteworthy that none of the peptide mixtures and individual peptides with antistaphylococcal activity had aspartic, P-aspartic, glutamic, or y-glutamic acid in their sequences.
Viable counts of S. aureus cells in the presence of (aFmocelys)WfR-NH2 were then carried out to determine if this representative peptide was bacteriostatic or bactericidal. As shown in Fig. 2 , (ctFmoc-elys)WfR-NH2 had bacteriostatic activity against S. aureus.
The tetrapeptides identified above were also tested against an MRSA strain. Twelve of the identified peptides had similar activities against the two strains of S. aureus, while decreases or losses in activity were observed for the remaining nine peptides.
Activity in the presence of serum. The activities of the tetrapeptides were also examined in the presence of various concentrations in human serum (Table 4 ). This furthers the measure of the therapeutic potentials of these peptides. The activities of all of the peptides tested decreased in the presence of 6.5% serum, with (aFmoc-elys)Wfl-NH2 having the greatest activity. Human serum albumin was then used to investigate if this decrease was due to enzyme inactivation or serum protein binding. As shown in Table 5 , higher levels of activity were found solely in the presence of human serum albumin.
Spectra of activity of the antistaphylococcal peptides. The antimicrobial activities of the peptides found to have antistaphylococcal activities were also assayed against a second gram-positive bacterium (S. sanguis), a gram-negative bacterium (E. coli), and a fungal species (C. albicans). The MICs of each of the tetrapeptides for these three microorganisms were compared with the MICs for S. aureus. Overall, these peptides were found to be more active against gram-positive bacteria. Thus, as seen in Table 3 , all of the peptides tested showed similar activities against the two gram-positive bacteria. Lower levels of activity, although similar within the series, were found for all of the tetrapeptides against E. coli and C. albicans, with the exception of (aFmoc-e1ys)Wfi-NH2 and (otFmoc-slys) WKC-NH2. (otFmoc-e1ys)Wfi-NH2 was highly selective for gram-positive bacteria, while (ctFmoc-e1ys)WKC-NH2 was active against bacteria but was inactive against C. albicans. Kinetic studies of the activity of (aFmoc-e1ys)WfR-NH2 against E. coli (Fig. 3) were carried out in a manner similar to that described above for S. aureus. Those studies indicated that (aoFmoc-s1ys)WfR-NH2 exhibits bacteriostatic activity against E. coli.
Hemolytic activity of the antistaphylococcal peptides. The ability of the antistaphylococcal peptides to lyse eukaryotic cells was determined by using human RBCs. The HD50 of each peptide was calculated ( Table 6 ). The HD5Os were generally found to be greater than the MICs for the gram-positive bacteria. At 16 j,g/ml, the concentration corresponding to the MICs for gram-positive bacteria, the majority of the peptides showed less than 5% hemolysis (Table 6 ). At a higher concentration (125 ,ug/ml), only (aFmoc-elys)Wfi-NH2 had no hemolytic activity, with (aFmoc-e1ys)WfL-NH2 and (aFmoc-elys) Wf(aAIB)-NH2 being 10 to 20% hemolytic (Table 5) . Interestingly, (otFmoc-s1ys)Wfi-NH2 was found to be the only peptide of the series highly selective for gram-positive bacteria.
DISCUSSION
The widespread use of antibiotics has caused numerous antibiotic-resistant strains to develop. For instance, MRSA is acquiring resistance to antibiotics such as the fluoroquinolones (for a review, see reference 5). With the emergence of vancomycin-resistant Enterococcus strains, there is concern that this resistance will be passed to MRSA. Such new resistant strains underscore the need for new antibiotics that are effective against them. The rational design of new antimicrobial agents requires years of effort to screen a large number of new compounds. The introduction of soluble combinatorial peptide and organic chemical libraries now enables the identification of antimicrobial agents in a matter of weeks. A series of successful uses of such SPCLs has been reported for the identification of biologically active peptide sequences in various assay systems such as enzyme-linked immunosorbent assays (15, 18) , radioreceptor assays (7), enzyme inhibitor assays (8) , and microdilution assays (11, 12, 14, 15) . In particular, investigators have identified a number of hexapeptides composed of Lamino acids which exhibit antimicrobial activities against S. aureus (11, 12, 15) and E. coli (14) . These new hexapeptides have MICs that vary from 3 to 20 jig/ml. These activities are greater or equivalent to those found for naturally occurring peptides, which are generally greater in length (i.e., 10 residues To expand the chemical diversity of the original SPCLs and to decrease the risk of enzymatic degradation in in vivo systems, D-and unnatural amino acids have been incorporated, thus permitting the screening of a larger variety of peptides. The generation of such libraries can be easily performed by using the divide, couple, and recombine synthetic approach (9, 15, 17) , which ensures the equimolarity of each peptide within a mixture. The tetrapeptide format was chosen so that the number of individual peptides in each peptide mixture was in the same range as that in the initial hexapeptide library used for the identification of new antimicrobial peptides (11, 12, 14, 15) .
The individual tetrapeptides found in the current study to exhibit antimicrobial activities against S. aureus were similar to those described earlier, which were made up of L-amino acids only. The greater antistaphylococcal activities observed for the non-N-acetylated peptide mixtures compared with the activities of the equivalent N-acetylated peptide mixtures suggests that hydrogen bonding or electrostatic interactions through the protonated N terminus are involved in the antimicrobial activities of these series of tetrapeptides. The lack of activity of those tetrapeptides with either a glutamic acid or an aspartic acid supports this hypothesis. The presence of negative charges in such peptides may prevent the initial electrostatic interactions between the peptides and the negatively charged phospholipids that make up the bacterial cells. The higher level of activity found for the (oFmoc-elys)ZZZ-NH2 mixture compared with that of the Ac-KZZZ-NH2 mixture, which differ only by their protecting N-terminal groups, may be due to the hydrophobicity of the Fmoc group relative to that of an acetyl group. Longer Fmoc-protected peptides have been reported to have potent antimicrobial activities (6) .
The tetrapeptides studied here appear to exhibit their VOL. 38, 1994 activities by inhibiting cell growth and development rather than lysing the cells. This effect may be due to the shortness of these peptides, which would prevent them from spanning the lipid bilayer of a membrane and/or forming a channel through the membranes, as has been proposed for longer antimicrobial peptides such as magainins (16) and cecropins (4) . Because of their cationic character, these short peptides may bind to the lipopolysaccharides of the bacterial cell membranes in a manner similar to that of the magainins (19) , thereby increasing cell permeability. This is supported by their higher levels of activity against gram-positive bacteria, which have a less complex cell wall and lack an outer membrane, compared with their activities against gram-negative bacteria. The results of the experiments with serum suggest that the activities of the tetrapeptides decrease because of degradation by heat-stable proteases rather than binding to serum proteins. Further studies are necessary to determine the cause of the decrease in activity that was observed. The studies described above indicate that new potent antimicrobial compounds can be readily and rapidly identified through the examination of extendeddiversity peptide libraries.
